Dr. Andrea Hawe

Dr. Andrea Hawe is the Chief Scientific Officer at Coriolis. She is an expert in drug product development for biologics with a strong scientific background in protein formulation, surfactant and particle characterization, and lyophilization process technology. Andrea has published more than 40 peer-reviewed papers and book chapters.

At Coriolis, Andrea is responsible for Science & Technology in close collaboration with Dr. Tim Menzen. She also leads the Coriolis Scientific Advisory Board. Andrea supports the business development and projects teams, the scientific advisors, and her internal team of scientific reviewers in developing new formulation concepts and designing the best project strategy for our clients. She continuously works to improve Coriolis’ scientific processes, scientific knowledge management, and staff training.

Andrea values Coriolis for the opportunity to work with our clients worldwide on developing very exciting and novel biopharmaceutical drug products. She is also passionate about creating a positive and motivating working environment where each team member’s contribution is encouraged to shape Coriolis Pharma’s future.

Her background is as a pharmacist with a PhD in Pharmaceutical Technology from the LMU Munich. After her PhD thesis, she continued her career as a postdoctoral scientist at the Leiden Academic Center for Drug Research (LACDR) in Leiden (The Netherlands). She was awarded a Veni grant (NWO, The Netherlands) to develop novel approaches for aggregate analysis. She joined Coriolis from the very beginning as a member of the founding team and has been supporting the company since 2008.